"Designing Growth Strategies is in our DNA"

Monoclonal Antibody Therapy Market Size, Share & COVID-19 Impact Analysis, By Type (Human mAb, Humanized mAb, Chimeric mAb, and Murine mAb), By Application (Cancer, Autoimmune Diseases, and Others), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2021-2028

Region : Global | Format: PDF | Report ID: FBI102734

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Major Diseases – For Key Countries
    2. Patent Snapshot
    3. Pipeline Analysis
    4. New Product Launches
    5. Key Industry Developments - Mergers, Acquisitions and Partnerships
    6. Key Industry Trends
  5. Global Monoclonal Antibody Therapy Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Human Monoclonal Antibody
      2. Humanized Monoclonal Antibody
      3. Chimeric Monoclonal Antibody
      4. Murine Monoclonal Antibody
    3. Market Analysis, Insights and Forecast – By Application
      1. Cancer
      2. Autoimmune Diseases
      3. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Monoclonal Antibody Therapy Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Human Monoclonal Antibody
      2. Humanized Monoclonal Antibody
      3. Chimeric Monoclonal Antibody
      4. Murine Monoclonal Antibody
    3. Market Analysis, Insights and Forecast – By Application
      1. Cancer
      2. Autoimmune Diseases
      3. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Monoclonal Antibody Therapy Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Human Monoclonal Antibody
      2. Humanized Monoclonal Antibody
      3. Chimeric Monoclonal Antibody
      4. Murine Monoclonal Antibody
    3. Market Analysis, Insights and Forecast – By Application
      1. Cancer
      2. Autoimmune Diseases
      3. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Countries/ Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia Pacific Monoclonal Antibody Therapy Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Human Monoclonal Antibody
      2. Humanized Monoclonal Antibody
      3. Chimeric Monoclonal Antibody
      4. Murine Monoclonal Antibody
    3. Market Analysis, Insights and Forecast – By Application
      1. Cancer
      2. Autoimmune Diseases
      3. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Countries/ Sub-region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific
  9. Latin America Monoclonal Antibody Therapy Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Human Monoclonal Antibody
      2. Humanized Monoclonal Antibody
      3. Chimeric Monoclonal Antibody
      4. Murine Monoclonal Antibody
    3. Market Analysis, Insights and Forecast – By Application
      1. Cancer
      2. Autoimmune Diseases
      3. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Countries/ Sub regions
      1. Brazil
      2. Mexico
      3. Rest of Latin America
  10. Middle East & Africa Monoclonal Antibody Therapy Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Human Monoclonal Antibody
      2. Humanized Monoclonal Antibody
      3. Chimeric Monoclonal Antibody
      4. Murine Monoclonal Antibody
    3. Market Analysis, Insights and Forecast – By Application
      1. Cancer
      2. Autoimmune Diseases
      3. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Pharmacy
    5. Market Analysis, Insights and Forecast – By Countries/ Sub region
      1. South Africa
      2. GCC
      3. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2020)
    3. Company Profiles (Overview, Types & Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. AbbVie Inc.
        1. Overview,
        2. Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Merck & Co., Inc
        1. Overview,
        2. Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. F.Hoffmann-La Roche Ltd.
        1. Overview,
        2. Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Bristol-Myers Squibb Company
        1. Overview,
        2. Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Johnson & Johnson Services, Inc.
        1. Overview,
        2. Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. Novartis AG
        1. Overview,
        2. Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Daiichi Sankyo Company, Limited
        1. Overview,
        2. Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Amgen Inc.
        1. Overview,
        2. Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. Alexion Pharmaceuticals, Inc.
        1. Overview,
        2. Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      10. Other Prominent Players
        1. Overview,
        2. Types & Services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
  12. Strategic Recommendations
Read Less

Figure 1:  Global Monoclonal Antibody Therapy Market Revenue Breakdown (USD Billion, %) by Region, 2020 & 2028

Figure 2:  Global Monoclonal Antibody Therapy Market Value Share (%), by Type, 2020 & 2028

Figure 3:  Global Monoclonal Antibody Therapy Market Forecast (USD Billion), by Human Monoclonal Antibody, 2017-2028

Figure 4:  Global Monoclonal Antibody Therapy Market Forecast (USD Billion), by Humanized Monoclonal Antibody, 2017-2028

Figure 5:  Global Monoclonal Antibody Therapy Market Forecast (USD Billion), by Chimeric Monoclonal Antibody, 2017-2028

Figure 6:  Global Monoclonal Antibody Therapy Market Forecast (USD Billion), by Murine Monoclonal Antibody, 2017-2028

Figure 7:  Global Monoclonal Antibody Therapy Market Value Share (%), by Application, 2020 & 2028

Figure 8:  Global Monoclonal Antibody Therapy Market Forecast (USD Billion), by Cancer, 2017-2028

Figure 9:  Global Monoclonal Antibody Therapy Market Forecast (USD Billion), by Autoimmune Diseases, 2017-2028

Figure 10:  Global Monoclonal Antibody Therapy Market Forecast (USD Billion), by Others, 2017-2028

Figure 11:  Global Monoclonal Antibody Therapy Market Value Share (%), by Distribution Channel, 2020 & 2028

Figure 12:  Global Monoclonal Antibody Therapy Market Forecast (USD Billion), by Hospital Pharmacy, 2017-2028

Figure 13:  Global Monoclonal Antibody Therapy Market Forecast (USD Billion), by Retail Pharmacy, 2017-2028

Figure 14:  Global Monoclonal Antibody Therapy Market Forecast (USD Billion), by Online Pharmacy, 2017-2028

Figure 15:  Global Monoclonal Antibody Therapy Market Value (USD Billion), by Region, 2020 & 2028

Figure 16:  North America Monoclonal Antibody Therapy Market Value (USD Billion), by Type, 2020 & 2028

Figure 17:  North America Monoclonal Antibody Therapy Market Value Share (%), by Type, 2020

Figure 18:  North America Monoclonal Antibody Therapy Market Value (USD Billion), by Application, 2020 & 2028

Figure 19:  North America Monoclonal Antibody Therapy Market Value Share (%), by Application, 2020

Figure 20:  North America Monoclonal Antibody Therapy Market Value (USD Billion), by Distribution Channel, 2020 & 2028

Figure 21:  North America Monoclonal Antibody Therapy Market Value Share (%), by Distribution Channel, 2020

Figure 22:  North America Monoclonal Antibody Therapy Market Value (USD Billion), By Country, 2020 & 2028

Figure 23:  North America Monoclonal Antibody Therapy Market Value Share (%), By Country, 2020

Figure 24:  Europe Monoclonal Antibody Therapy Market Value (USD Billion), by Type, 2020 & 2028

Figure 25:  Europe Monoclonal Antibody Therapy Market Value Share (%), by Type, 2020

Figure 26:  Europe Monoclonal Antibody Therapy Market Value (USD Billion), by Application, 2020 & 2028

Figure 27:  Europe Monoclonal Antibody Therapy Market Value Share (%), by Application, 2020

Figure 28:  Europe Monoclonal Antibody Therapy Market Value (USD Billion), by Distribution Channel, 2020 & 2028

Figure 29:  Europe Monoclonal Antibody Therapy Market Value Share (%), by Distribution Channel, 2020

Figure 30:  Europe Monoclonal Antibody Therapy Market Value (USD Billion), By Country/ Sub-region, 2020 & 2028

Figure 31:  Europe Monoclonal Antibody Therapy Market Value Share (%), By Country/ Sub-region, 2020

Figure 32:  Asia Pacific Monoclonal Antibody Therapy Market Value (USD Billion), by Type, 2020 & 2028

Figure 33:  Asia Pacific Monoclonal Antibody Therapy Market Value Share (%), by Type, 2020

Figure 34:  Asia Pacific Monoclonal Antibody Therapy Market Value (USD Billion), by Application, 2020 & 2028

Figure 35:  Asia Pacific Monoclonal Antibody Therapy Market Value Share (%), by Application, 2020

Figure 36:  Asia Pacific Monoclonal Antibody Therapy Market Value (USD Billion), by Distribution Channel, 2020 & 2028

Figure 37:  Asia Pacific Monoclonal Antibody Therapy Market Value Share (%), by Distribution Channel, 2020

Figure 38:  Asia Pacific Monoclonal Antibody Therapy Market Value (USD Billion), By Country/ Sub-region, 2020 & 2028

Figure 39:  Asia Pacific Monoclonal Antibody Therapy Market Value Share (%), By Country/ Sub-region, 2020

Figure 40:  Latin America Monoclonal Antibody Therapy Market Value (USD Billion), by Type, 2020 & 2028

Figure 41:  Latin America Monoclonal Antibody Therapy Market Value Share (%), by Type, 2020

Figure 42:  Latin America Monoclonal Antibody Therapy Market Value (USD Billion), by Application, 2020 & 2028

Figure 43:  Latin America Monoclonal Antibody Therapy Market Value Share (%), by Application, 2020

Figure 44:  Latin America Monoclonal Antibody Therapy Market Value (USD Billion), by Distribution Channel, 2020 & 2028

Figure 45:  Latin America Monoclonal Antibody Therapy Market Value Share (%), by Distribution Channel, 2020

Figure 46:  Latin America Monoclonal Antibody Therapy Market Value (USD Billion), By Country/ Sub-region, 2020 & 2028

Figure 47:  Latin America Monoclonal Antibody Therapy Market Value Share (%), By Country/ Sub-region, 2020

Figure 48:  Middle East & Africa Monoclonal Antibody Therapy Market Value (USD Billion), by Type, 2020 & 2028

Figure 49:  Middle East & Africa Monoclonal Antibody Therapy Market Value Share (%), by Type, 2020

Figure 50:  Middle East & Africa Monoclonal Antibody Therapy Market Value (USD Billion), by Application, 2020 & 2028

Figure 51:  Middle East & Africa Monoclonal Antibody Therapy Market Value Share (%), by Application, 2020

Figure 52:  Middle East & Africa Monoclonal Antibody Therapy Market Value (USD Billion), by Distribution Channel, 2020 & 2028

Figure 53:  Middle East & Africa Monoclonal Antibody Therapy Market Value Share (%), by Distribution Channel, 2020

Figure 54:  Middle East & Africa Monoclonal Antibody Therapy Market Value (USD Billion), By Country/ Sub-region, 2020 & 2028

Figure 55:  Middle East & Africa Monoclonal Antibody Therapy Market Value Share (%), By Country/ Sub-region, 2020

Figure 56:  Global Monoclonal Antibody Therapy Market Share (%), By Company, 2020

Table 1:  Global Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Type, 2017–2028

Table 2:  Global Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Application, 2017–2028

Table 3:  Global Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Distribution Channel, 2017–2028

Table 4:  Global Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Region, 2017-2028

Table 5:  North America Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Type, 2017-2028

Table 6:  North America Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Application, 2017-2028

Table 7:  North America Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Distribution Channel, 2017-2028

Table 8:  North America Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, By Country, 2017-2028

Table 9:  Europe Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Type, 2017-2028

Table 10:  Europe Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Application, 2017-2028

Table 11:  Europe Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Distribution Channel, 2017-2028

Table 12:  Europe Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2017-2028

Table 13:  Asia Pacific Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Type, 2017-2028

Table 14:  Asia Pacific Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Application, 2017-2028

Table 15:  Asia Pacific Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Distribution Channel, 2017-2028

Table 16:  Asia Pacific Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2017-2028

Table 17:  Latin America Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Type, 2017-2028

Table 18:  Latin America Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Application, 2017-2028

Table 19:  Latin America Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Distribution Channel, 2017-2028

Table 20:  Latin America Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2017-2028

Table 21:  Middle East & Africa Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Type, 2017-2028

Table 22:  Middle East & Africa Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, by Application, 2017-2028

Table 23:  Middle East & Africa Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, By Distribution Channel, 2017-2028

Table 24:  Middle East & Africa Monoclonal Antibody Therapy Market Revenue (USD Billion) Forecast, By Country/ Sub-region, 2017-2028

 class=
  • Aug, 2021
  • 2020
  • 2017-2019
  • 135

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Book Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X